Darmowy Stock Screener
Load Zapisać Utwórz listę obserwacyjną Help| Symbol | Firma | Giełda | Przemysł | Kapitalizacja rynkowa | EBITDA | P/E | EV/EBITDA | Dług / kapitał własny | Średnia objętość | Własność instytucjonalna | Data zarobków | Cena | Wydajność dzisiejsza |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | NASDAQ | Drug Manufacturers - General | $215.52B | $12.522B | 38.81 | 17.81 | 1.58 | 3.433M | 18.45% | N/A | $80.53 | -0.78% |
| AMGN | AMGEN Inc. | NASDAQ | Pharmaceuticals | $153.35B | $11.266B | 56.41 | 20.43 | 14.59 | N/A | 82.11% | 5 Nov 2024 | $329.98 | +0.32% |
| SNY | Sanofi | NASDAQ | Drug Manufacturers - General | $114.45B | €13.168B | 29.62 | 9.61 | 0.70 | 2.278M | 10.08% | N/A | $57.46 | -1.15% |
| GILD | Gilead Sciences, Inc. | NASDAQ | Pharmaceuticals | $112.22B | $12.178B | 95.22 | 9.78 | 1.72 | N/A | 82.11% | 7 Nov 2024 | $80.94 | -0.61% |
| ISRG | Intuitive Surgical Inc | NASDAQ | Health Care Supplies | $99.18B | $2.008B | 82.93 | 51.22 | 0.15 | N/A | 87.25% | 17 Oct 2024 | $490.93 | +1.38% |
| REGN | Regeneron Pharmaceuticals, Inc. | NASDAQ | Biotechnologia | $81.68B | $4.548B | 28.31 | 26.69 | 0.27 | 499.031k | 88.20% | 31 Oct 2024 | $1,141.45 | +0.45% |
| MRNA | Moderna Inc | NASDAQ | Biotechnologia | $80.27B | -$4.11 | N/A | N/A | 0.33 | 5.181M | 64.21% | 31 Oct 2024 | $79.51 | +0.29% |
| VRTX | Vertex Pharmaceuticals, Inc. | NASDAQ | Biotechnologia | $79.58B | $4.629B | N/A | 16.91 | 0.29 | 1.018M | 94.14% | 4 Nov 2024 | $474.74 | +0.84% |
| BNTX | BioNTech SE | NASDAQ | Biotechnologia | $45.15B | €8.298B | N/A | 1.26 | 0.14 | N/A | 15.47% | 4 Nov 2024 | $99.27 | -1.35% |
| BIIB | Biogen Inc | NASDAQ | Pharmaceuticals | $41.92B | $2.267B | 24.98 | 15.18 | 0.81 | N/A | 87.31% | 6 Nov 2024 | $199.09 | -0.77% |
| ALXN | Alexion Pharmaceuticals Inc. | NASDAQ | Biotechnologia | $40.34B | $3.180B | 58.49 | N/A | 1.50 | 0.000 | 88.27% | N/A | $183.08 | +2.02% |
| IDXX | Idexx Laboratories, Inc. | NASDAQ | Life Sciences Tools & Services | $35.61B | $1.204B | 48.11 | 34.28 | 1.20 | N/A | 89.97% | 6 Nov 2024 | $490.26 | -1.15% |
| ILMN | Illumina Inc | NASDAQ | Life Sciences Tools & Services | $33.03B | $245.000M | N/A | 91.29 | 0.76 | 1.515M | 88.93% | 7 Nov 2024 | $124.83 | +0.56% |
| GMAB | Genmab | NASDAQ | Biotechnologia | $29.44B | N/A | 7.09 | N/A | N/A | N/A | 6.03% | 6 Nov 2024 | $26.93 | -2.07% |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Biotechnologia | $29.16B | $157.972M | N/A | 216.73 | -18.36 | N/A | 94.71% | 31 Oct 2024 | $261.91 | +2.22% |
| CERN | Cerner Corp. | NASDAQ | Health Care Technology | $27.92B | $809.272M | 47.70 | N/A | 1.89 | N/A | 82.42% | N/A | $94.96 | -0.01% |
| HZNP | Horizon Therapeutics Plc | NASDAQ | Pharmaceuticals | $25.49B | $900.373M | 60.57 | N/A | 1.75 | N/A | 93.75% | N/A | $116.30 | +0.00% |
| SGEN | Seagen Inc | NASDAQ | Biotechnologia | $23.02B | -$666.67 | N/A | N/A | 1.33 | 0.000 | 91.25% | N/A | $228.86 | -0.02% |
| PODD | Insulet Corporation | NASDAQ | Health Care Equipment | $21.66B | $348.200M | 40.31 | 39.07 | 2.53 | 785.700k | 100.00% | 7 Nov 2024 | $227.73 | +0.54% |
| ARGX | Argen X SE | NASDAQ | Biotechnologia | $21.57B | N/A | N/A | N/A | N/A | 536.800k | 63.21% | 31 Oct 2024 | $537.43 | +0.45% |
| BGNE | BeiGene Ltd | NASDAQ | Biotechnologia | $21.42B | -$883.15 | N/A | N/A | 0.64 | N/A | 63.15% | 11 Nov 2024 | $211.15 | +6.80% |
| IMMU | Immunomedics, Inc. | NASDAQ | Biotechnologia | $20.31B | N/A | N/A | N/A | N/A | 0.000 | 81.31% | N/A | $87.86 | +0.05% |
| BMRN | Biomarin Pharmaceutical Inc. | NASDAQ | Biotechnologia | $19.51B | $298.308M | 62.80 | 58.47 | 0.38 | 2.086M | 98.81% | 30 Oct 2024 | $84.78 | -0.08% |
| HOLX | Hologic, Inc. | NASDAQ | Health Care Supplies | $18.61B | $1.196B | 27.12 | 15.84 | 0.82 | N/A | 98.55% | 7 Nov 2024 | $80.01 | -2.38% |
| INCY | Incyte Corp. | NASDAQ | Biotechnologia | $18.31B | $120.890M | 166.13 | 89.90 | 0.31 | N/A | 96.09% | 5 Nov 2024 | $63.13 | +0.00% |
| RPRX | Royalty Pharma plc | NASDAQ | Biotechnologia | $17.52B | $942.794M | 18.40 | 19.27 | 0.62 | 4.362M | 63.29% | 7 Nov 2024 | $27.78 | -1.00% |
| ABMD | Abiomed Inc. | NASDAQ | Health Care Equipment | $17.29B | $281.669M | 64.91 | N/A | 1.10 | 0.000 | 94.64% | N/A | $381.02 | +0.06% |
| PPD | PPD Inc | NASDAQ | Drug Manufacturers—Specialty & Generic | $16.61B | $976.134M | 45.90 | 20.16 | -16.56 | N/A | 79.44% | N/A | $47.28 | -0.06% |
| ICLR | Icon Plc | NASDAQ | Life Sciences Tools & Services | $15.90B | $1.720B | 43.26 | 17.21 | 0.84 | N/A | 99.34% | 23 Oct 2024 | $289.81 | +3.33% |
| ALGN | Align Technology, Inc. | NASDAQ | Health Care Equipment | $15.30B | $823.389M | 38.16 | 20.38 | 0.68 | N/A | 91.86% | 23 Oct 2024 | $225.15 | -0.88% |
| LVGO | Livongo Health, Inc. | NASDAQ | Health Care Equipment | $14.20B | N/A | N/A | N/A | N/A | 0.000 | 73.48% | N/A | $139.77 | -3.87% |
| TECH | Bio-Techne Corp | NASDAQ | Biotechnologia | $13.63B | $358.872M | 68.68 | 32.58 | 0.31 | 1.271M | 95.84% | 31 Oct 2024 | $73.49 | -0.39% |
| VTRS | Viatris Inc. | NASDAQ | Pharmaceuticals | $13.47B | $5.242B | 224.40 | 6.17 | 1.33 | 8.024M | 75.32% | N/A | $11.34 | +1.52% |
| UTHR | United Therapeutics Corp | NASDAQ | Biotechnologia | $12.63B | $1.324B | 14.99 | 9.95 | 0.20 | N/A | 100.00% | 30 Oct 2024 | $346.19 | +1.09% |
| MYOK | MyoKardia, Inc. | NASDAQ | Biotechnologia | $11.99B | N/A | N/A | N/A | N/A | 0.000 | 100.00% | N/A | $224.91 | +0.05% |
| NBIX | Neurocrine Biosciences, Inc. | NASDAQ | Biotechnologia | $11.46B | $569.400M | 35.41 | 24.93 | 0.46 | N/A | 97.75% | 31 Oct 2024 | $121.47 | +1.99% |
| DXCM | Dexcom Inc | NASDAQ | Life Sciences Tools & Services | $11.27B | $679.900M | 40.04 | 42.22 | 2.03 | N/A | 98.78% | 24 Oct 2024 | $68.47 | -0.12% |
| HSIC | Henry Schein Inc. | NASDAQ | Health Care Distributors | $11.26B | $862.000M | 24.56 | 13.01 | 1.48 | N/A | 98.25% | 7 Nov 2024 | $67.05 | -0.74% |
| QGEN | Qiagen N.V. | NASDAQ | Life Sciences Tools & Services | $11.22B | $855.551M | 35.45 | 13.58 | 0.81 | 1.101M | 73.51% | N/A | $45.84 | -0.13% |
| XLRN | Acceleron Pharma Inc | NASDAQ | Biotechnologia | $10.93B | -$251.26 | 0.00 | N/A | 1.10 | 0.000 | 90.60% | N/A | $178.75 | -0.52% |
| PRAH | PRA Health Sciences Inc | NASDAQ | Life Sciences Tools & Services | $10.70B | $435.158M | 49.32 | N/A | 2.75 | 0.000 | 96.81% | N/A | $165.21 | -1.67% |
| SRPT | Sarepta Therapeutics Inc | NASDAQ | Biotechnologia | $10.39B | -$509.08 | 171.19 | N/A | 2.80 | 1.372M | 84.59% | 6 Nov 2024 | $128.39 | +1.14% |
| RGEN | Repligen Corp. | NASDAQ | Biotechnologia | $9.85B | $194.038M | N/A | 47.61 | 0.43 | N/A | 93.28% | 29 Oct 2024 | $143.40 | -2.25% |
| JAZZ | Jazz Pharmaceuticals plc | NASDAQ | Biotechnologia | $9.69B | $1.204B | 16.74 | 8.96 | 2.05 | 2.883M | 97.33% | 6 Nov 2024 | $105.13 | -1.84% |
| BRKR | Bruker Corp | NASDAQ | Life Sciences Tools & Services | $9.50B | $556.100M | 26.55 | 21.29 | 2.06 | N/A | 71.23% | 31 Oct 2024 | $63.99 | +1.06% |
| EXAS | Exact Sciences Corp. | NASDAQ | Life Sciences Tools & Services | $8.95B | -$170.38 | N/A | N/A | 1.06 | N/A | 88.77% | 30 Oct 2024 | $64.12 | +9.83% |
| LEGN | Legend Biotech Corp | NASDAQ | Biotechnologia | $8.68B | -$354.91 | N/A | N/A | 0.48 | 962.165k | 32.08% | N/A | $49.75 | -0.10% |
| MYL | Mylan NV | NASDAQ | Pharmaceuticals | $8.59B | N/A | 32.42 | N/A | N/A | 14.110M | 87.96% | N/A | $15.85 | +1.96% |
| CHNG | Change Healthcare Inc | NASDAQ | Health Care Technology | $8.56B | $820.226M | 0.00 | N/A | 2.93 | N/A | 94.74% | N/A | $27.49 | +0.26% |
| NVCR | NovoCure Ltd | NASDAQ | Health Care Supplies | $8.26B | -$173.86 | N/A | N/A | 2.16 | N/A | 75.94% | 24 Oct 2024 | $17.23 | +1.95% |
Sign up
